인비트로 전사 템플릿 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global in-vitro transcription templates market size is expected to reach USD 5.67 Billion in 2034 from USD 1.10 Billion in 2025, growing at a CAGR of 19.98% during 2026-2034.The Global In-Vitro Transcription Templates Market is experiencing strong growth due to the increasing focus on genetic research and biotechnology advancements. These templates are essential for synthesizing RNA molecules in laboratory settings, which are widely used in vaccine development, gene therapy, and molecular biology studies. The growing demand for mRNA-based vaccines and therapeutics has significantly accelerated market expansion in recent years.

Research institutions and pharmaceutical companies are investing heavily in advanced genetic technologies. The rapid progress in personalized medicine and the increasing number of research projects related to rare diseases and cancer are driving demand for reliable transcription templates. Government funding for life sciences research and collaborations between biotech firms are also supporting the market's growth globally.

In the future, the market is expected to benefit from expanding applications in synthetic biology and drug discovery. Continuous innovation in template design and production methods will improve efficiency and reduce costs. As biotechnology continues to evolve and mRNA therapies gain wider acceptance, the in-vitro transcription templates market is likely to witness sustained growth and new opportunities worldwide.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• DNA Templates
• RNA Templates
• Templates And Transcription Kits
• Other Product Types

By Disease

• Cancer
• Infectious Disease
• Lifestyle Disease
• Genetic Disease
• Other Diseases

By Treatment

• Vaccine
• Therapeutic

By Research Stage

• Exploratory
• Clinical

By End-Use

• Biotechnology And Pharmaceutical Companies
• Academic And Research Institutes
• Contract Research Organizations

COMPANIES PROFILED

• Agilent Technologies Inc., Bio-Synthesis Inc., Bio-Rad Laboratories Inc., Cinven Limited, Danaher Corporation, Enzynomics Co Ltd., Enzo Biochem Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., LGC Limited, Merck KGaA

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. DNA Templates Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. RNA Templates Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Templates And Transcription Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Product Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY DISEASE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease
• 5.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Infectious Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Lifestyle Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Genetic Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY TREATMENT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Treatment
• 6.2. Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Therapeutic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY RESEARCH STAGE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Research Stage
• 7.2. Exploratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Biotechnology And Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product Type
  • 9.2.2 By Disease
  • 9.2.3 By Treatment
  • 9.2.4 By Research Stage
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product Type
  • 9.3.2 By Disease
  • 9.3.3 By Treatment
  • 9.3.4 By Research Stage
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product Type
  • 9.4.2 By Disease
  • 9.4.3 By Treatment
  • 9.4.4 By Research Stage
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product Type
  • 9.5.2 By Disease
  • 9.5.3 By Treatment
  • 9.5.4 By Research Stage
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product Type
  • 9.6.2 By Disease
  • 9.6.3 By Treatment
  • 9.6.4 By Research Stage
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies Inc
  • 11.2.2 Bio-Synthesis Inc
  • 11.2.3 Bio-Rad Laboratories Inc
  • 11.2.4 Cinven Limited
  • 11.2.5 Danaher Corporation
  • 11.2.6 Enzynomics Co Ltd
  • 11.2.7 Enzo Biochem Inc
  • 11.2.8 F. Hoffmann-La Roche Ltd
  • 11.2.9 Illumina Inc
  • 11.2.10 LGC Limited
  • 11.2.11 Merck KGaA